Fonte: Clinical Infectious Diseases. Unidade: FMRP
Assuntos: INFECÇÕES POR HIV, IMUNIZAÇÃO, GRAVIDEZ, IMUNOGENICIDADE DA VACINA, FARMACOTERAPIA, STREPTOCOCCUS PNEUMONIAE
ABNT
MUSSI-PINHATA, Marisa Márcia et al. Effect of maternal immunization with 10-valent pneumococcus conjugate vaccine (PCV-10), 23-valent pneumococcus polysaccharide vaccine, or placebo on the immunogenicity of PCV-10 in human immunodeficiency virus-exposed uninfected infants: a randomized clinical trial. Clinical Infectious Diseases, v. 75, n. 6, p. 996-1005, 2022Tradução . . Disponível em: https://doi.org/10.1093/cid/ciac026. Acesso em: 20 ago. 2024.APA
Mussi-Pinhata, M. M., Ward, S., Laimon, L., Pelton, S. I., Canniff, J., Golner, A., et al. (2022). Effect of maternal immunization with 10-valent pneumococcus conjugate vaccine (PCV-10), 23-valent pneumococcus polysaccharide vaccine, or placebo on the immunogenicity of PCV-10 in human immunodeficiency virus-exposed uninfected infants: a randomized clinical trial. Clinical Infectious Diseases, 75( 6), 996-1005. doi:10.1093/cid/ciac026NLM
Mussi-Pinhata MM, Ward S, Laimon L, Pelton SI, Canniff J, Golner A, Bone F, Newton L, Muresan P, Fenton T, Johnson MJ, João EC, Santos BR, Pilotto JH, Oliveira RH, Pinto JA, Bó AGBLD, Kreitchmann R, Chakhtoura N, Duarte G, Weinberg A. Effect of maternal immunization with 10-valent pneumococcus conjugate vaccine (PCV-10), 23-valent pneumococcus polysaccharide vaccine, or placebo on the immunogenicity of PCV-10 in human immunodeficiency virus-exposed uninfected infants: a randomized clinical trial [Internet]. Clinical Infectious Diseases. 2022 ; 75( 6): 996-1005.[citado 2024 ago. 20 ] Available from: https://doi.org/10.1093/cid/ciac026Vancouver
Mussi-Pinhata MM, Ward S, Laimon L, Pelton SI, Canniff J, Golner A, Bone F, Newton L, Muresan P, Fenton T, Johnson MJ, João EC, Santos BR, Pilotto JH, Oliveira RH, Pinto JA, Bó AGBLD, Kreitchmann R, Chakhtoura N, Duarte G, Weinberg A. Effect of maternal immunization with 10-valent pneumococcus conjugate vaccine (PCV-10), 23-valent pneumococcus polysaccharide vaccine, or placebo on the immunogenicity of PCV-10 in human immunodeficiency virus-exposed uninfected infants: a randomized clinical trial [Internet]. Clinical Infectious Diseases. 2022 ; 75( 6): 996-1005.[citado 2024 ago. 20 ] Available from: https://doi.org/10.1093/cid/ciac026